INVO Fertility, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by INVO Fertility, Inc. (Nasdaq: IVF) on September 29, 2025. The report details a material definitive agreement entered into on the same date regarding the restructuring of existing debt obligations.
Key Financial Metrics
The filing does not provide standard financial metrics such as revenue, profit, cash flow, or operating margins. The primary financial event reported is the extinguishment of debt through an equity exchange:
- Debt Extinguished: A Second Amended and Restated Senior Secured Convertible Debenture due February 11, 2026, held by Five Narrow Lane LP ("FNL").
- Equity Issued: 467 additional shares of Series C-2 Convertible Preferred Stock.
- Transaction Value: The exchanged debenture had an aggregated stated value of $1,334,000.
Material Changes
The material change reported is the full repayment and extinguishment of the Second Amended and Restated Debenture. This transaction was executed via an Amendment and Exchange Agreement, converting the debt obligation into equity (Series C-2 Preferred Stock) rather than a cash settlement.
Guidance, Outlook, and Risks
The filing contains no forward-looking guidance, management commentary on future operations, or specific risk factors beyond the standard legal disclosures. The transaction was executed under exemptions from registration provided by Sections 3(a)(9) and 4(a)(2) of the Securities Act of 1933.
Investor Verification Checklist
- Verify the terms of the Series C-2 Convertible Preferred Stock, including conversion rates and liquidation preferences, in the attached Exhibit 10.1 (Exchange Agreement).
- Confirm the total outstanding debt load of the company post-transaction to assess remaining leverage.
- Review the impact of the 467 new preferred shares on the existing capital structure and potential dilution to common shareholders.
- Check subsequent filings for any additional debt restructuring or liquidity events.